Product design firm BlackHägen Design’s founder, Sean Hägen and industrial designers Bartosz Korec and James Brown are named contributors on a multi-country medical device patent involving an innovative auto-injector design.
In conjunction with the BlackHägen designers, medical device developer PreciHealth designed a solution for self-vaccination and remote medical treatment. This miniaturised auto-injector technology permits different volumetric capabilities ranging from 25 mm3 to 2,500 mm3. These smaller, user-friendly devices are easier to carry and have been developed for simple and safe administration. Their small size helps facilitate seamless integration with other platforms such as robotics, microsurgery tools and endoscopes, telemedicine IoT, and veterinary applications.
Alain Jaccard, chief innovation officer at PreciHealth, said: "During our collaboration with BlackHägen Design, we were impressed with their fast reaction time and user-centred methodologies. They succeeded in addressing the constraints of the complex inside mechanism of our device while ensuring its ease of use for the patient.”
Receiving approval on this patent from several countries (Europe, Switzerland, Japan, China, and patent pending in the US), supports the BlackHägen objective to be an instrumental design research and usability design partner for its customers in medical device, healthcare, and pharmaceutical industries.
Sean Hägen, BlackHägen Design principal, founder and director of research and synthesis, said: “We were excited receiving the news of this patent approval, as it validates and protects the uniqueness of the design, a key differentiator for our client. The power of user-centric design and engineering techniques was instrumental in developing this auto-injector.”
A strategic patent portfolio can be crucial for a medical device company’s growth and survival and can help secure funding, which is vital for bringing to new products to market.
